One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Coronary Stent Market

[ 英語タイトル ] Coronary Stent Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0083189
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Abbott Laboratories
- B. Braun Medical Inc.
- Biosensors International Group, Ltd.
- Boston Scientific Corporation
- Cook Medical Technologies
- Medtronic PLC
- Terumo Corporation
- Translumina GmbH

[Report Description]

The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.

The prevalence of coronary artery disease (CAD) has increased in the past three decades in the low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus, with the increased burden of CAD, the usage of coronary stents has increased significantly in healthcare facilities as well as their production by the medical device manufacturers, thus helping in driving the market growth. In addition, the increasing geriatric population has also increased the demand for coronary stents that is expected to rise over the forecast period.

There has also been a high demand for minimally invasive surgical procedures, which significantly drives the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.

Key Market Trends

Drug-eluting Stent is the Largest Segment by Product Type, Expected to do Same Over the Forecast Period

The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.

According to a survey conducted by European Heart Network in 2017, 3.9 million deaths in Europe were due to cardiovascular diseases. The increasing prevalence of cardiovascular diseases is also a major factor in the growth of the segment.

North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period

North America holds the largest market share for coronary stents, due to the dominance of the top companies present in the global market. There is also an increase in the aging population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market. According to the American College of Cardiology (2017), Cardiovascular disease accounts for 800,000 deaths in the United States. the increasing patient pool is boosting the market growth in the region.

Competitive Landscape

The major companies have adopted strategies like mergers and acquisitions and strategic alliances to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
4.2.2 Rising of the Geriatric Population
4.2.3 Technological Advancements in Coronary Stents
4.3 Market Restraints
4.3.1 High Product Recalls
4.3.2 Stringent Approval Process for Stents
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 Product Type
5.1.1 Drug Eluting Stent
5.1.2 Bare Metal Coronary Stent
5.1.3 Bioabsorbable Stent
5.2 By Biomaterial
5.2.1 Mettalic Biomaterial
5.2.2 Polymeric Biomaterial
5.2.3 Natual Biomaterial
5.3 End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Medical Inc.
6.1.3 Biosensors International Group, Ltd.
6.1.5 Boston Scientific Corporation
6.1.6 Cook Medical Technologies
6.1.7 Medtronic PLC
6.1.8 Terumo Corporation
6.1.9 Translumina GmbH




Recommended reports